Key points are not available for this paper at this time.
TEVAR established as choice for complicated TBAD; Level 5 evidence leaves durability and comparative questions open.
Since its initial use in treating TBAD was reported in 1999, thoracic endovascular aortic repair (TEVAR) has evolved as the treatment of choice for complicated descending thoracic aortic dissections [1-6].
No takes yet. Share an insight, caveat, or question.
Halim Yammine (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: